LONDON, April 16 (Reuters) - The sale of Actavis, one of the world’s biggest generic drugmakers, has been halted because of disagreements over price and a dearth of suitors, several sources familiar with the matter said.
LONDON, April 16 (Reuters) - The sale of Actavis, one of the world’s biggest generic drugmakers, has been halted because of disagreements over price and a dearth of suitors, several sources familiar with the matter said.